Vitreoretinal Surgery Devices Market Report 2026

Vitreoretinal Surgery Devices Market Overview

• Vitreoretinal Surgery Devices market size has reached to $2.13 billion in 2025 • Expected to grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: The Surge In Minimally Invasive Surgeries Fuels Expansion Of The Vitreoretinal Surgery Devices Market • Market Trend: Next-Generation Integrated Surgical Platforms Transform Vitreoretinal Procedure Precision And Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vitreoretinal Surgery Devices Market?

Vitreoretinal surgery devices are specialized medical instruments that have typically incorporated a peristaltic pump, a venturi pump, or a combination of both to manage fluids. It is used for the removal of core vitrectomy, membrane cutting, and hyaloid and vitreous bases. These vitreoretinal surgical instruments feature improved flow control and less retinal traction. The main product types of vitreoretinal surgery devices are photocoagulation lasers, illumination devices, vitrectomy machines, vitrectomy probes, vitreoretinal packs, and others. Photocoagulation lasers refer to medical devices that are used to shrink or destroy abnormal structures in the retina. The various surgery includes anterior vitreoretinal surgery, and posterior vitreoretinal surgery. These are used in various applications such as diabetic vitreous hemorrhage, retinal detachment, macular hole, and others, used by various end-users such as hospitals, specialty clinics, ambulatory surgery centers, and others.

What Is The Vitreoretinal Surgery Devices Market Growth Forecast?

The vitreoretinal surgery devices market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for precision retinal surgeries, rising investments in ophthalmic innovation, expansion of ambulatory surgery centers, growing focus on patient safety outcomes, increased adoption of digitally assisted surgery. Major trends in the forecast period include increasing use of advanced fluid control systems, rising adoption of integrated vitreoretinal platforms, growing demand for high-speed vitrectomy probes, expansion of single-use surgical accessories, enhanced focus on reduced retinal trauma.

Global Vitreoretinal Surgery Devices Market Segmentation

1) By Product: Photocoagulation Lasers, Illumination Devices, Vitrectomy Machines, Vitrectomy Probes, Vitreoretinal Packs, Other Products 2) By Surgery: Anterior Vitreoretinal Surgery, Posterior Vitreoretinal Surgery 3) By Application: Diabetic Vitreous Hemorrhage, Retinal Detachment, Macular Hole, Other Applications 4) By End-Users: Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Other End-Users Subsegments: 1) By Photocoagulation Lasers: Argon Lasers, Diode Lasers, Solid-State Lasers 2) By Illumination Devices: Fiber Optic Illumination Devices, LED Illumination Devices, Halogen Illumination Devices 3) By Vitrectomy Machines: 20-Gauge Vitrectomy Systems, 23-Gauge Vitrectomy Systems, 25-Gauge Vitrectomy Systems 4) By Vitrectomy Probes: Single-Use Vitrectomy Probes, Multi-Use Vitrectomy Probes 5) By Vitreoretinal Packs: Single-Use Vitreoretinal Packs, Multi-Use Vitreoretinal Packs 6) By Other Products: Surgical Instruments, Fluid Management Systems, Scleral Buckles

What Is The Driver Of The Vitreoretinal Surgery Devices Market?

The rising number of minimally invasive surgeries is expected to propel the growth of the vitreoretinal surgery devices market going forward. Minimally invasive surgeries (MIS) are medical procedures performed to achieve therapeutic effects while minimizing trauma to the body. Vitreoretinal surgery devices play a crucial role in minimally invasive surgeries by enabling precise interventions within the eye, typically through small incisions. These advanced devices enhance visualization, facilitate delicate procedures, and contribute to quicker recovery times in vitreoretinal surgeries. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based specialty organization, a 7 percent growth in minimally invasive procedures in 2023 surpassed surgical procedures by 2 percent, with neuromodulator injections and hyaluronic acid fillers each exceeding 9 million and 5 million treatments, respectively. Therefore, the rising number of minimally invasive surgeries is driving the growth of the vitreoretinal surgery devices industry.

Key Players In The Global Vitreoretinal Surgery Devices Market

Major companies operating in the vitreoretinal surgery devices market are Alcon Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., D.O.R.C. Dutch Ophthalmic Research Center B.V., Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers Ltd, Geuder AG, BVI Medical Inc., MedOne Surgical Inc., Oculus Optikgeräte GmbH, Inami & Co. Ltd, Hoya Corporation, Nidek Co. Ltd, Leica Microsystems GmbH, Katalyst Surgical LLC, Synergetics USA Inc., Lumenis Ltd, Optos plc, Alimera Sciences Inc., Oertli Instrumente AG, MicroSurgical Technology Inc

Global Vitreoretinal Surgery Devices Market Trends and Insights

Major companies operating in the vitreoretinal surgery devices market are focusing on developing advanced solutions, such as integrated surgical platforms, to improve surgical precision, procedural efficiency, and patient outcomes. Integrated surgical platforms refer to comprehensive vitreoretinal systems that combine fluidics, high-speed cutting, micro-injection, and a wide range of surgical instruments into a unified workflow, enabling surgeons to perform complex procedures with greater accuracy and control. For instance, in October 2024, Carl Zeiss Meditec AG, a Germany-based medical technology company, expanded its D.O.R.C. EVA NEXUS vitreo-retinal surgical system as part of the ZEISS Retina Workflow during its AAO 2024 announcement. The EVA NEXUS system incorporates a VTi pump with advanced FLOW & VACUUM fluidics, a TDC vitrectomy cutter capable of speeds up to 20,000 cuts per minute (CPM), the EVA INICIO micro-injection system, and a range of posterior instruments, including 27G ULTRA instruments and surgical liquids/tamponades, designed to streamline vitreoretinal surgeries and enhance clinical decision-making.

What Are Latest Mergers And Acquisitions In The Vitreoretinal Surgery Devices Market?

In April 2024, Carl Zeiss Meditec AG, a Germany-based provider of ophthalmic medical devices, visualization systems, and digitally connected surgical workflows, acquired Dutch Ophthalmic Research Center (D.O.R.C.) for an undisclosed amount. With this acquisition, the company aims to broaden its ophthalmic portfolio, strengthen its position in the vitreoretinal surgery segment, and expand its integrated digital workflow capabilities across retina and cataract procedures. D.O.R.C. is a Netherlands-based provider of advanced vitreoretinal surgical platforms, instruments, consumables, and ophthalmic surgical solutions used in retina and combined cataract surgeries.

Regional Outlook

North America was the largest region in the vitreoretinal surgery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global vitreoretinal surgery devices market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vitreoretinal Surgery Devices Market?

The vitreoretinal surgery devices market consists of sales squeezers, luer locks, forceps, and surgical instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.